Cervical Cancer

There are racial/ethnic inequalities in cervical cancer screening in the United States, but an outcome reclassification may lead to better interventions. Data shows that cervical cancer mortality is preventable through early detection. Pap smears and high-risk human papillomavirus screening aid in identifying cancer, but national data show that from 2013 to 2018, only 53% of...

Despite HPV vaccinations being widely available, HPV-associated cervical cancer still disproportionally affects Black and Latino women. Research finds that underserved women are less likely to receive HPV vaccine recommendations from their healthcare providers. Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, impacting many individuals in their late teens and...

This year, it is estimated that 14,100 women will be diagnosed with invasive cervical cancer in the United States [1]. When compared to non-Hispanic white women, African American women have a significantly higher rate of cervical cancer and a higher death rate from cervical cancer. These statistics call for a deeper understanding of why a...

Most accredited cancer programs in the United States reported a decline in cancer screening during the pandemic, most notably in colorectal cancer, according to a study published in Cancer. Rachel H. Joung, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues conducted a prospective, national quality improvement study involving 748 accredited cancer...

The early months of the COVID-19 pandemic kept millions of Americans away from routine cancer screenings. Now a new study finds that many U.S. screening programs were still not back to normal by 2021. The study of more than 700 cancer facilities nationwide found that in January 2021 — a year after COVID’s emergence in...

A COVID-19 diagnosis can lead to potentially life-threatening treatment delays for women with gynecological cancers, a new study finds. That’s especially true for non-white patients, the researchers said. “We found that concurrent COVID-19 had significant negative effects on these cancer patients, especially among those who identified as Black or Asian,” said study leader Dr. Gretchen...

The recent decrease in the incidence of cervical cancers, particularly in young women, may be associated with human papillomavirus (HPV) vaccination approval, according to a study published in JAMA Network Open. Cheng-I Liao, M.D., from the Kaohsiung Veterans General Hospital in Taiwan, and colleagues examined the association between vaccination availability and the incidence of HPV-attributable cancers....

The incidence of human papillomavirus (HPV)-associated cancers is beginning to increase, with greater increases seen in the lowest-income counties and counties with high smoking prevalence, according to research published in the April issue of JNCI Cancer Spectrum. Yueh-Yun Lin, from the UTHealth School of Public Health in Houston, and colleagues used the Surveillance, Epidemiology, and End...

For patients with recurrent cervical cancer after first-line platinum-containing chemotherapy, survival is significantly longer with cemiplimab than with single-agent chemotherapy, according to a study published in the Feb. 10 issue of the New England Journal of Medicine. Krishnansu S. Tewari, M.D., from the University of California in Irvine, and colleagues enrolled patients with recurrent cervical cancer...